Intravesical and systemic chemotherapy of murine bladder cancer.
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001500:BCG Vaccine / Q000627:therapeutic use; D002295:Carcinoma, Transitional Cell / Q000139:chemically induced / Q000188:drug therapy* / Q000473:pathology; D002945:Cisplatin / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D003609:Dactinomycin / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005009:Ethoglucid / Q000627:therapeutic use; D005200:FANFT; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D051379:Mice; D008809:Mice, Inbred C3H; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000139:chemically induced / Q000473:pathology / Q000628:therapy; D011034:Podophyllotoxin / Q000627:therapeutic use; D013852:Thiotepa / Q000627:therapeutic use; D001749:Urinary Bladder Neoplasms / Q000139:chemically induced / Q000188:drug therapy* / Q000473:pathology
D000970:Antineoplastic Agents; D001500:BCG Vaccine; D003609:Dactinomycin; D005009:Ethoglucid; D005200:FANFT; D004317:Doxorubicin; D003520:Cyclophosphamide; D013852:Thiotepa; D011034:Podophyllotoxin; D002945:Cisplatin; D005472:Fluorouracil